Teladoc Health (NYSE:TDOC) Receives Hold Rating from Needham & Company LLC

Needham & Company LLC reaffirmed their hold rating on shares of Teladoc Health (NYSE:TDOC) in a research report released on Friday, Benzinga reports.

TDOC has been the subject of a number of other research reports. Truist Financial dropped their target price on shares of Teladoc Health from $23.00 to $17.00 and set a hold rating for the company in a research report on Wednesday, March 6th. Leerink Partnrs reiterated a market perform rating on shares of Teladoc Health in a research report on Monday, February 26th. Royal Bank of Canada dropped their target price on shares of Teladoc Health from $30.00 to $25.00 and set an outperform rating for the company in a research report on Wednesday, February 21st. Cantor Fitzgerald began coverage on shares of Teladoc Health in a research report on Thursday, February 29th. They set an overweight rating and a $22.00 target price for the company. Finally, Canaccord Genuity Group lowered their price objective on shares of Teladoc Health from $34.00 to $28.00 and set a buy rating for the company in a research report on Wednesday, February 21st. Eleven investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of Hold and a consensus target price of $19.67.

Teladoc Health Price Performance

NYSE:TDOC opened at $13.01 on Friday. The company has a 50-day moving average of $15.01 and a 200-day moving average of $17.77. Teladoc Health has a 52 week low of $12.65 and a 52 week high of $30.41. The company has a quick ratio of 3.47, a current ratio of 3.54 and a debt-to-equity ratio of 0.66.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings data on Thursday, April 25th. The health services provider reported ($0.49) EPS for the quarter, missing analysts’ consensus estimates of ($0.47) by ($0.02). The business had revenue of $646.13 million for the quarter, compared to the consensus estimate of $637.31 million. Teladoc Health had a negative return on equity of 10.11% and a negative net margin of 8.90%. Teladoc Health’s revenue was up 2.7% on a year-over-year basis. During the same period in the previous year, the business posted ($0.37) earnings per share. As a group, research analysts forecast that Teladoc Health will post -1.07 EPS for the current fiscal year.

Insider Transactions at Teladoc Health

In other news, EVP Andrew Turitz sold 6,190 shares of Teladoc Health stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $14.52, for a total transaction of $89,878.80. Following the completion of the sale, the executive vice president now owns 39,429 shares in the company, valued at approximately $572,509.08. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In related news, COO Michael Willem Waters sold 4,523 shares of Teladoc Health stock in a transaction that occurred on Friday, February 2nd. The shares were sold at an average price of $19.18, for a total transaction of $86,751.14. Following the transaction, the chief operating officer now owns 38,570 shares of the company’s stock, valued at approximately $739,772.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Andrew Turitz sold 6,190 shares of Teladoc Health stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $14.52, for a total transaction of $89,878.80. Following the transaction, the executive vice president now directly owns 39,429 shares in the company, valued at approximately $572,509.08. The disclosure for this sale can be found here. Insiders sold a total of 135,441 shares of company stock worth $2,038,251 in the last quarter. 1.63% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the company. Lecap Asset Management Ltd. bought a new position in Teladoc Health during the 4th quarter worth approximately $1,530,000. Sowell Financial Services LLC boosted its stake in Teladoc Health by 40.8% during the 4th quarter. Sowell Financial Services LLC now owns 18,907 shares of the health services provider’s stock worth $407,000 after acquiring an additional 5,475 shares during the last quarter. Deutsche Bank AG lifted its stake in Teladoc Health by 12.4% in the third quarter. Deutsche Bank AG now owns 301,147 shares of the health services provider’s stock valued at $5,598,000 after buying an additional 33,287 shares in the last quarter. Sherbrooke Park Advisers LLC bought a new position in Teladoc Health in the third quarter valued at approximately $680,000. Finally, QRG Capital Management Inc. bought a new position in Teladoc Health in the third quarter valued at approximately $392,000. Institutional investors own 76.82% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.